Basic Information
| LncRNA/CircRNA Name | LINC00668 |
| Synonyms | NA |
| Region | GRCh38_18:6919496-6929966 |
| Ensemble | ENSG00000265933 |
| Refseq | NR_034100 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, Luciferase reporter assay, RIP etc. |
| Sample | glioblastoma tissues and normal tissues, cell lines(T98G, U87, U251 and A172) |
| Expression Pattern | up-regulated |
| Function Description | Upregulation of LINC00668 Induces Glioma Cell Proliferation.LINC00668 Could Sponge miR-518c-3p in Glioma Cells |
| Pubmed ID | 32279214 |
| Year | 2020 |
| Title | LINC00668 Modulates SOCS5 Expression Through Competitively Sponging miR-518c-3p to Facilitate Glioma Cell Proliferation. |
External Links
| Links for LINC00668 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |